PFG Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,331
Closed -$323K 797
2026
Q1
$323K Sell
5,331
-96
-2% -$5.6K 0.02% 637
2025
Q4
$293K Sell
5,427
-922
-15% -$44.4K 0.01% 651
2025
Q3
$286K Buy
+6,349
New +$297K 0.01% 692
2025
Q2
Sell
-4,642
Closed -$283K 632
2025
Q1
$283K Buy
4,642
+70
+2% +$4.08K 0.02% 599
2024
Q4
$259K Sell
4,572
-350
-7% -$19.6K 0.02% 620
2024
Q3
$255K Buy
4,922
+40
+0.8% +$1.88K 0.02% 630
2024
Q2
$203K Sell
4,882
-65
-1% -$2.91K 0.01% 648
2024
Q1
$268K Sell
4,947
-702
-12% -$35.8K 0.02% 549
2023
Q4
$290K Buy
5,649
+323
+6% +$17K 0.02% 491
2023
Q3
$309K Sell
5,326
-4,489
-46% -$275K 0.03% 444
2023
Q2
$628K Buy
9,815
+192
+2% +$12.9K 0.05% 367
2023
Q1
$667K Buy
9,623
+250
+3% +$17.6K 0.06% 341
2022
Q4
$674K Buy
9,373
+99
+1% +$7.46K 0.07% 310
2022
Q3
$659K Buy
9,274
+1,146
+14% +$83.1K 0.08% 287
2022
Q2
$626K Buy
8,128
+1,398
+21% +$106K 0.07% 225
2022
Q1
$492K Buy
6,730
+1,313
+24% +$88.2K 0.05% 269
2021
Q4
$338K Sell
5,417
-840
-13% -$49.3K 0.03% 418
2021
Q3
$370K Sell
6,257
-30
-0.5% -$1.98K 0.04% 379
2021
Q2
$420K Sell
6,287
-517
-8% -$33.7K 0.05% 347
2021
Q1
$430K Buy
6,804
+3,338
+96% +$208K 0.06% 319
2020
Q4
$215K Sell
3,466
-44
-1% -$2.71K 0.04% 349
2020
Q3
$212K Buy
+3,510
New +$211K 0.04% 332
2020
Q2
Sell
-3,331
Closed -$205K 308
2020
Q1
$205K Buy
+3,331
New +$204K 0.06% 265

Other funds holding BMY

PFG Advisors's BMY Position: Q2 2026 in Review

PFG Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 5,331 shares — an estimated $323K sold.

PFG Advisors first reported a position in BMY in Q1 2020 and held it in 23 quarters. The position peaked at $674K in Q4 2022. 852 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • PFG Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • PFG Advisors sold 5,331 Bristol-Myers Squibb shares in Q2 2026, an estimated $323K.
  • PFG Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 23 quarters.
  • PFG Advisors's Bristol-Myers Squibb position peaked at $674K in Q4 2022.
  • 852 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.